1161602-22-7 Usage
General Description
1-(phenoxycarbonyl)pyrrolidine-2-carboxylic acid is a chemical compound with the molecular formula C13H15NO5. It is a derivative of pyrrolidine-2-carboxylic acid, containing a phenoxycarbonyl group attached to the nitrogen atom. 1-(phenoxycarbonyl)pyrrolidine-2-carboxylic acid has potential applications in medicinal chemistry, particularly in the development of pharmaceuticals and biologically active molecules. It may also have uses in organic synthesis and as a building block for the creation of more complex chemical structures. The specific properties and potential uses of 1-(phenoxycarbonyl)-pyrrolidine-2-carboxylic acid will depend on its reactivity, stability, and interactions with other molecules. Additional research and experimentation may be necessary to fully understand the characteristics and potential applications of this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 1161602-22-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,6,1,6,0 and 2 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1161602-22:
(9*1)+(8*1)+(7*6)+(6*1)+(5*6)+(4*0)+(3*2)+(2*2)+(1*2)=107
107 % 10 = 7
So 1161602-22-7 is a valid CAS Registry Number.
1161602-22-7Relevant articles and documents
PROCESS FOR THE PREPARATION OF 5-SUBSTSITUTED INDOLE DERIVATIVE
-
Page/Page column 28, (2012/02/01)
The present invention relates to an improved and industrially advantageous process for preparation of eletri tan of formula I,or pharmaceutically acceptable salts thereof from bromo indole intermediate of formula II, through isolation of N-acetylated bromo indole intermediate of formula III, to elude carrying forward of impurities to next stage. The present invention relates to process for the preparation of 5-bromo-3-[(R)-l-methyl-pyrrolidin-2- lmeth l -lH-indol of formula II, a key intermediate for the synthesis of eletriptan or pharmaceutically acceptable salts thereof, through novel keto carbamate intermediate. The present invention also relates to novel process for the preparation of a-form of eletriptan hydrobromide.
